Canadian Syncope Risk Score (CSRS) Calculator

Clinical calculation support · Verify results before clinical use

Risk assessment

Complete the eligibility screen and select the findings from the index emergency department assessment.

—Total score

Eligibility check

The CSRS was derived for patients aged 16 years or older presenting to the ED within 24 hours of true syncope, after serious conditions identified during the initial ED evaluation have been excluded.

Exclusion screen

Select any exclusion that applies. The calculator will not produce a CSRS estimate if one is present.

Clinical evaluation

1

Predisposition to vasovagal symptoms

Syncope triggered by a warm, crowded place; prolonged standing; fear; emotion; or pain.

−1 point
2

History of heart disease

Includes coronary or valvular heart disease, cardiomyopathy, congestive heart failure, or a nonsinus rhythm (documented arrhythmia or implanted cardiac device).

+1 point
3

Abnormal systolic blood pressure

Any SBP reading from ED triage until ED disposition was <90 mmHg or >180 mmHg.

+2 points

Investigations

Use the laboratory assay's 99th-percentile upper reference limit and the ECG measurements from the index ED assessment. For missing investigations, the original validation protocol imputed the corresponding predictor as normal.

4

Elevated troponin

Troponin concentration above the 99th percentile of the normal reference population for the assay used.

+2 points
5

Abnormal QRS axis

QRS axis <−30° or >100°.

+1 point
6

QRS duration

QRS duration >130 ms.

+1 point
7

Corrected QT interval (QTc)

QTc >480 ms.

+2 points

Emergency department diagnosis

8–9

ED physician diagnosis

Select the single most appropriate ED diagnosis after the initial evaluation. The two scored diagnoses are mutually exclusive.

−2 to +2 points
—CSRS
30-day serious adverse event risk
Complete all required fields
No risk estimate calculated.
Clinical interpretationConfirm eligibility and complete each score component to calculate the CSRS.

The score estimates serious adverse events within 30 days after ED assessment; it is not a diagnostic test and must not replace clinical judgement.

About the Canadian Syncope Risk Score

The Canadian Syncope Risk Score (CSRS) is a clinical prediction rule designed to estimate the probability of a serious adverse event within 30 days after an emergency department assessment for syncope. It combines clinical history, blood pressure, troponin, ECG findings, and the ED physician's diagnostic impression.

It is intended for patients with true syncope after the initial ED evaluation has not identified a serious underlying condition. It should not be used to reassure clinicians when a serious diagnosis is already apparent.

Score components

PredictorCriterionPoints
Vasovagal predispositionWarm/crowded place, prolonged standing, fear, emotion, or pain−1
Heart disease historyCoronary/valvular disease, cardiomyopathy, heart failure, nonsinus rhythm/arrhythmia or implanted device+1
ED systolic BPAny reading <90 or >180 mmHg+2
Troponin>99th percentile of normal population+2
QRS axis<−30° or >100°+1
QRS duration>130 ms+1
QTc>480 ms+2
ED diagnosisVasovagal syncope / Cardiac syncope−2 / +2

Score-specific estimated risk

The following are shrinkage-adjusted expected probabilities from the original derivation model. Scores of 6 or higher were grouped for reporting in the derivation and validation publications; individual estimates shown here are from the original model.

ScoreEstimated 30-day riskRisk category
−30.4%Very low
−20.7%Very low
−11.2%Low
01.9%Low
13.1%Medium
25.1%Medium
38.1%Medium
412.9%High
519.7%High
6–1128.9%–83.6%Very high

Risk categories and observed outcomes in the Canadian validation cohort

CategoryScoreObserved 30-day serious outcomes
Very low−3 to −20.2%
Low−1 to 00.7%
Medium1 to 38.0%
High4 to 519.2%
Very high6 to 1151.3%

Evidence and references

Thiruganasambandamoorthy V, et al.Development of the Canadian Syncope Risk Score to predict serious adverse events after emergency department assessment of syncope. CMAJ. 2016;188(12):E289–E298. DOI: 10.1503/cmaj.151469.
Thiruganasambandamoorthy V, et al.Multicenter Emergency Department Validation of the Canadian Syncope Risk Score. JAMA Intern Med. 2020;180(5):737–744. DOI: 10.1001/jamainternmed.2020.0288.
Zimmermann T, et al.International Validation of the Canadian Syncope Risk Score: A Cohort Study. Ann Intern Med. 2022;175(6):783–794. DOI: 10.7326/M21-2313.
Solbiati M, et al.Multicentre external validation of the Canadian Syncope Risk Score to predict adverse events and comparison with clinical judgement. Emerg Med J. 2021. DOI: 10.1136/emermed-2020-210579.
Validation of 2 Syncope Risk Scores and Comparison With Physician Risk Estimation.JAMA Network Open. Published May 19, 2026. DOI: 10.1001/jamanetworkopen.2026.17362. US cohort (n=1,263; age ≥40; syncope or presyncope): CSRS AUROC 0.72 (95% CI 0.67–0.78); CSRS <0 had 91.9% sensitivity and 97.5% NPV. CSRS was not significantly more sensitive than physician estimates, while FAINT was more sensitive for serious cardiac outcomes. The cohort and outcome definitions differ from the original CSRS studies.
European Society of Cardiology.2018 ESC Guidelines for the diagnosis and management of syncope. Official guideline page: ESC Syncope Guideline. The guideline provides general syncope evaluation and risk-stratification recommendations; it is not the source of the CSRS point weights.
Clinical disclaimer: The CSRS is a prognostic aid, not a diagnostic instrument or an automatic admission/discharge rule. It was developed for ED patients with syncope after serious conditions evident during the index evaluation have been excluded. Risk estimates may vary across populations and healthcare settings. Interpret the result with the full clinical assessment, ECG, laboratory findings, comorbidities, and local protocols. Do not delay investigation or treatment of a suspected serious cause to calculate this score.